The Potential Role of Zinc Oxide Nanoparticles in the Treatment of Diabetes Mellitus: An Updated Review

IS APELIN A PROMISING TARGET IN DIABETES MELLITUS OF RATS: TYPE I VS. TYPE II?

MicroRNA-146a and Metabolic Disorder

THE POSSIBLE ANTIDIABETIC ROLE OF SELECTIVE p3 ADRENOCEPTOR AGONIST IN ANIMAL MODELS OF DIABETES MELLITUS.

Role of AGE-RAGE Pathway in the Pathogenesis of Cardiovascular Disease as a Complication of Diabetes Mellitus

The Possible Antidiabetic Effects of Ranolazine Versus Gliclazide In HFD/STZ-Induced Type 2 Diabetes In Male Albino Rats

Epigenetic and Diabetes Mellitus Type 1

Association of Plasma Sialic Acid concentrations with Diabetic Nephropathy in Syrian Individuals with Type 2 Diabetes Mellitus

Modulation of cardio-metabolic disorders by Tocilizumab in rats with fructose-induced metabolic syndrome: Role of cardiac NLRP3 Inflammasome and TIMP1..

Biochemical changes in lipid peroxidation and anti oxidative defense following lipoic acid administration in alloxan-induced diabetes in rats